Gene · 4610
Papers2,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Small molecule Z363 co-regulates TAF10 and MYC via the E3 ligase TRIP12 to suppress tumour growth. | Clin Transl Med | 2023 | 36639831 | PubTator, text mining | PubMed |
| Control of protein stability by post-translational modifications. | Nat Commun | 2023 | 36639369 | PubTator, text mining | PubMed |
| NeuroLINCS Proteomics: Defining human-derived iPSC proteomes and protein signatures of pluripotency. | Sci Data | 2023 | 36631473 | PubTator, text mining | PubMed |
| Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditis. | Stem Cell Res | 2023 | 36630840 | PubTator, text mining | PubMed |
| Crystal structure of a covalently linked Aurora-A-MYCN complex. | Acta Crystallogr D Struct Biol | 2023 | 36601802 | PubTator, text mining | PubMed |
| The Landmark Series: Intraductal Papillary Mucinous Neoplasms of the Pancreas-From Prevalence to Early Cancer Detection. | Ann Surg Oncol | 2023 | 36600097 | PubTator, text mining | PubMed |
| Grave-to-cradle: human embryonic lineage tracing from the postmortem body. | Exp Mol Med | 2023 | 36599930 | PubTator, text mining | PubMed |
| Targeting BRD4 and PI3K signaling pathways for the treatment of medulloblastoma. | J Control Release | 2023 | 36599397 | PubTator, text mining | PubMed |
| Establishment of NCHi009-A, an iPSC line from a patient with hypoplastic left heart syndrome (HLHS) carrying a heterozygous NOTCH1 mutation. | Stem Cell Res | 2023 | 36599283 | PubTator, text mining | PubMed |
| Nanomedicine for renal cell carcinoma: imaging, treatment and beyond. | J Nanobiotechnology | 2023 | 36597108 | PubTator, text mining | PubMed |
| Generation of Induced Pluripotent Stem Cells from Lymphoblastoid Cell Lines by Electroporation of Episomal Vectors. | Int J Stem Cells | 2023 | 36581370 | PubTator, text mining | PubMed |
| Stem cell therapy in retinal diseases. | Neural Regen Res | 2023 | 36571345 | PubTator, text mining | PubMed |
| Eukaryotic translation initiation factor eIF4G2 opens novel paths for protein synthesis in development, apoptosis and cell differentiation. | Cell Prolif | 2023 | 36547008 | PubTator, text mining | PubMed |
| Circulating CD133+/–CD34– Have Increased c-MYC Expression in Myeloproliferative Neoplasms | Turk J Haematol | 2023 | 36458557 | PubTator, text mining | PubMed |
| Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations. | Cancer Med | 2023 | 36404592 | PubTator, text mining | PubMed |
| Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes. | Cancer Discov | 2023 | 36399432 | PubTator, text mining | PubMed |
| Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. | Cancer Res | 2023 | 36318118 | PubTator, text mining | PubMed |
| RISING STARS: Heterogeneity and the tumor microenvironment in neuroendocrine prostate cancer. | J Endocrinol | 2023 | 36286645 | PubTator, text mining | PubMed |
| Molecular subtyping of small-cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies. | Cancer Sci | 2023 | 36178064 | PubTator, text mining | PubMed |
| Advances in insulin therapy from discovery to β-cell replacement. | J Diabetes Investig | 2023 | 36074333 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4610/papers?page=18